PD­1/PD­L1 Inhibitors Show Safety and Efficacy in Advanced Ovarian Cancer

Dr. Disis writes an article for Targeted Oncology discussing results of two clinical studies presented at the 2015 American Society for Clinical Oncology meeting. (Jun 2015)